Požymis
Nausea
A sensation of unease in the stomach together with an urge to vomit.
Santrauka
- Kūno sistema
- Abnormality of the digestive system
Atskaitos genomasGRCh38hg38
Pozicijos genų ir variantų puslapiuose rodomos pagal šį pasirinkimą šioje naršyklėje.
Read the genes linked to Nausea, and the rest of your genome, with one test.
Nuo 449 $Nemokamas pristatymas · Rezultatai per 6–8 savaites
Įsigyti savo Genome Test102 genų susiję su Nausea
Šių genų pakitimai sukelia retas ligas, kuriose pasireiškia Nausea. Dauguma žmonių, turinčių šį požymį, neturi nė vienos iš tų ligų, o šiame sąraše esantis genas nieko nesako apie kieno nors paties genomą.
| Genas | Kaip dažnai pasireiškia | Ligos |
|---|---|---|
| ATP1A2ATPase Na+/K+ transporting subunit alpha 2 | Visada | 1 ligoje |
| GKglycerol kinase | Visada | 1 ligoje |
| IL18BPinterleukin 18 binding protein | Visada | 1 ligoje |
| ITPR3inositol 1,4,5-trisphosphate receptor type 3 | Visada | 1 ligoje |
| FSHRfollicle stimulating hormone receptor | Labai dažnai (80–99%) | 2 ligose |
| LIG3DNA ligase 3 | Labai dažnai (80–99%) | 1 ligoje |
| POLGDNA polymerase gamma, catalytic subunit | Labai dažnai (80–99%) | 1 ligoje |
| RRM2Bribonucleotide reductase regulatory TP53 inducible subunit M2B | Labai dažnai (80–99%) | 1 ligoje |
| TYMPthymidine phosphorylase | Labai dažnai (80–99%) | 1 ligoje |
| ALDOBaldolase, fructose-bisphosphate B | Dažnai (30–79%) | 2 ligose |
| COL1A1collagen type I alpha 1 chain | Dažnai (30–79%) | 1 ligoje |
| COL5A1collagen type V alpha 1 chain | Dažnai (30–79%) | 1 ligoje |
| COL5A2collagen type V alpha 2 chain | Dažnai (30–79%) | 1 ligoje |
| CPOXcoproporphyrinogen oxidase | Dažnai (30–79%) | 1 ligoje |
| CTRCchymotrypsin C | Dažnai (30–79%) | 1 ligoje |
| DLSTdihydrolipoamide S-succinyltransferase | Dažnai (30–79%) | 1 ligoje |
| DNMT3ADNA methyltransferase 3 alpha | Dažnai (30–79%) | 1 ligoje |
| EPAS1endothelial PAS domain protein 1 | Dažnai (30–79%) | 1 ligoje |
| EXT2exostosin glycosyltransferase 2 | Dažnai (30–79%) | 1 ligoje |
| FHfumarate hydratase | Dažnai (30–79%) | 1 ligoje |
| HPGD15-hydroxyprostaglandin dehydrogenase | Dažnai (30–79%) | 1 ligoje |
| KCNA1potassium voltage-gated channel subfamily A member 1 | Dažnai (30–79%) | 1 ligoje |
| KIF1Bkinesin family member 1B | Dažnai (30–79%) | 1 ligoje |
| MAXMYC associated transcriptional regulator X | Dažnai (30–79%) | 1 ligoje |
| MDH2malate dehydrogenase 2 | Dažnai (30–79%) | 1 ligoje |
| MGME1mitochondrial genome maintenance exonuclease 1 | Dažnai (30–79%) | 2 ligose |
| NAGSN-acetylglutamate synthase | Dažnai (30–79%) | 1 ligoje |
| NF1neurofibromin 1 | Dažnai (30–79%) | 1 ligoje |
| NR0B1nuclear receptor subfamily 0 group B member 1 | Dažnai (30–79%) | 1 ligoje |
| RETret proto-oncogene | Dažnai (30–79%) | 2 ligose |
| RRM1ribonucleotide reductase catalytic subunit M1 | Dažnai (30–79%) | 1 ligoje |
| RYR1ryanodine receptor 1 | Dažnai (30–79%) | 1 ligoje |
| SAA1serum amyloid A1 | Dažnai (30–79%) | 1 ligoje |
| SDHAsuccinate dehydrogenase complex flavoprotein subunit A | Dažnai (30–79%) | 1 ligoje |
| SDHAF2succinate dehydrogenase complex assembly factor 2 | Dažnai (30–79%) | 1 ligoje |
| SDHBsuccinate dehydrogenase complex iron sulfur subunit B | Dažnai (30–79%) | 2 ligose |
| SDHCsuccinate dehydrogenase complex subunit C | Dažnai (30–79%) | 1 ligoje |
| SDHDsuccinate dehydrogenase complex subunit D | Dažnai (30–79%) | 2 ligose |
| SERPING1serpin family G member 1 | Dažnai (30–79%) | 1 ligoje |
| SIsucrase-isomaltase | Dažnai (30–79%) | 1 ligoje |
Rodyti dar 62 genų
| Genas | Kaip dažnai pasireiškia | Ligos |
|---|---|---|
| SLC25A11solute carrier family 25 member 11 | Dažnai (30–79%) | 1 ligoje |
| SLCO2A1solute carrier organic anion transporter family member 2A1 | Dažnai (30–79%) | 1 ligoje |
| SPINK1serine peptidase inhibitor Kazal type 1 | Dažnai (30–79%) | 1 ligoje |
| TMEM127transmembrane protein 127 | Dažnai (30–79%) | 1 ligoje |
| VHLvon Hippel-Lindau tumor suppressor | Dažnai (30–79%) | 2 ligose |
| ALADaminolevulinate dehydratase | Kartais (5–29%) | 1 ligoje |
| ASXL1ASXL transcriptional regulator 1 | Kartais (5–29%) | 1 ligoje |
| CACNA1Dcalcium voltage-gated channel subunit alpha1 D | Kartais (5–29%) | 1 ligoje |
| CD46CD46 molecule | Kartais (5–29%) | 1 ligoje |
| CDKN1Bcyclin dependent kinase inhibitor 1B | Kartais (5–29%) | 1 ligoje |
| CDKN2Bcyclin dependent kinase inhibitor 2B | Kartais (5–29%) | 1 ligoje |
| CFHcomplement factor H | Kartais (5–29%) | 1 ligoje |
| CFIcomplement factor I | Kartais (5–29%) | 1 ligoje |
| CLCN2chloride voltage-gated channel 2 | Kartais (5–29%) | 1 ligoje |
| CYP11B1cytochrome P450 family 11 subfamily B member 1 | Kartais (5–29%) | 1 ligoje |
| CYP11B2cytochrome P450 family 11 subfamily B member 2 | Kartais (5–29%) | 1 ligoje |
| DNAJC6DnaJ heat shock protein family (Hsp40) member C6 | Kartais (5–29%) | 1 ligoje |
| FASFas cell surface death receptor | Kartais (5–29%) | 1 ligoje |
| HELLPARHELLP associated long non-coding RNA | Kartais (5–29%) | 1 ligoje |
| HLA-DRB1major histocompatibility complex, class II, DR beta 1 | Kartais (5–29%) | 1 ligoje |
| HTRA2HtrA serine peptidase 2 | Kartais (5–29%) | 1 ligoje |
| KCNJ5potassium inwardly rectifying channel subfamily J member 5 | Kartais (5–29%) | 1 ligoje |
| KCNQ2potassium voltage-gated channel subfamily Q member 2 | Kartais (5–29%) | 1 ligoje |
| KITKIT proto-oncogene, receptor tyrosine kinase | Kartais (5–29%) | 2 ligose |
| LRRK2leucine rich repeat kinase 2 | Kartais (5–29%) | 1 ligoje |
| MEN1menin 1 | Kartais (5–29%) | 1 ligoje |
| NPPAnatriuretic peptide A | Kartais (5–29%) | 1 ligoje |
| OXCT13-oxoacid CoA-transferase 1 | Kartais (5–29%) | 1 ligoje |
| PARK7Parkinsonism associated deglycase | Kartais (5–29%) | 1 ligoje |
| PINK1PTEN induced kinase 1 | Kartais (5–29%) | 1 ligoje |
| PKHD1PKHD1 ciliary IPT domain containing fibrocystin/polyductin | Kartais (5–29%) | 1 ligoje |
| PODXLpodocalyxin like | Kartais (5–29%) | 1 ligoje |
| PPOXprotoporphyrinogen oxidase | Kartais (5–29%) | 1 ligoje |
| PRKNparkin RBR E3 ubiquitin protein ligase | Kartais (5–29%) | 1 ligoje |
| PTPN22protein tyrosine phosphatase non-receptor type 22 | Kartais (5–29%) | 1 ligoje |
| SCN2Asodium voltage-gated channel alpha subunit 2 | Kartais (5–29%) | 1 ligoje |
| SCN5Asodium voltage-gated channel alpha subunit 5 | Kartais (5–29%) | 1 ligoje |
| SLC22A12solute carrier family 22 member 12 | Kartais (5–29%) | 1 ligoje |
| SLC2A9solute carrier family 2 member 9 | Kartais (5–29%) | 1 ligoje |
| SNCAsynuclein alpha | Kartais (5–29%) | 1 ligoje |
| SRSF2serine and arginine rich splicing factor 2 | Kartais (5–29%) | 1 ligoje |
| STAT3signal transducer and activator of transcription 3 | Kartais (5–29%) | 1 ligoje |
| SYNJ1synaptojanin 1 | Kartais (5–29%) | 1 ligoje |
| TET2tet methylcytosine dioxygenase 2 | Kartais (5–29%) | 1 ligoje |
| TRANK1tetratricopeptide repeat and ankyrin repeat containing 1 | Kartais (5–29%) | 1 ligoje |
| UCHL1ubiquitin C-terminal hydrolase L1 | Kartais (5–29%) | 1 ligoje |
| VPS13Cvacuolar protein sorting 13 homolog C | Kartais (5–29%) | 1 ligoje |
| PHKA2phosphorylase kinase regulatory subunit alpha 2 | Retai (1–4 %) | 1 ligoje |
| PHKBphosphorylase kinase regulatory subunit beta | Retai (1–4 %) | 1 ligoje |
| PHKG2phosphorylase kinase catalytic subunit gamma 2 | Retai (1–4 %) | 1 ligoje |
| EDNRAendothelin receptor type A | Neužfiksuota | 1 ligoje |
| ESR1estrogen receptor 1 | Neužfiksuota | 1 ligoje |
| ETFAelectron transfer flavoprotein subunit alpha | Neužfiksuota | 1 ligoje |
| ETFBelectron transfer flavoprotein subunit beta | Neužfiksuota | 1 ligoje |
| ETFDHelectron transfer flavoprotein dehydrogenase | Neužfiksuota | 1 ligoje |
| GLAgalactosidase alpha | Neužfiksuota | 1 ligoje |
| HMBShydroxymethylbilane synthase | Neužfiksuota | 1 ligoje |
| LPLlipoprotein lipase | Neužfiksuota | 1 ligoje |
| SLC1A3solute carrier family 1 member 3 | Neužfiksuota | 1 ligoje |
| SLC7A7solute carrier family 7 member 7 | Neužfiksuota | 1 ligoje |
| TNFtumor necrosis factor | Neužfiksuota | 1 ligoje |
| TP53tumor protein p53 | Neužfiksuota | 1 ligoje |
Kaip dažnai šis požymis pasitaiko žmonėms, turintiems vieną iš geno sukeliamų ligų, ir kuris dažnis tarp jų didžiausias, pagal Žmogaus fenotipo ontologijos duomenis. Šiuose puslapiuose aprašomi požymiai ir juos grindžiantys tyrimai; tai nėra diagnozė, o su simptomais kreipkitės į gydytoją ar genetikos konsultantą.
Platesni požymiai
Iš kur tai žinoma
- Žmogaus fenotipo ontologija, 2026-09-01 leidimas: požymis, jo pavadinimai, apibrėžimas ir su juo susiję genai. Daugiau sužinokite svetainėje hpo.jax.org.
- Duomenų leidimas 2026.10.16-c6eea6bf.
Vienas testas. Atsakymai visam gyvenimui.
Nuo 449 $Nemokamas pristatymas · Rezultatai per 6–8 savaites